BAX 855 PK-guided Dosing

Summary

BAX 855 PK-guided Dosing is a clinical trial^[1].

Key Facts

• BAX 855 PK-guided Dosing is located in Hong Kong^[2].
• BAX 855 PK-guided Dosing is in the country of Australia^[3].
• BAX 855 PK-guided Dosing is in the country of Austria^[4].
• BAX 855 PK-guided Dosing is in the country of Bulgaria^[5].
• BAX 855 PK-guided Dosing is in the country of France^[6].
• BAX 855 PK-guided Dosing is in the country of Germany^[7].
• BAX 855 PK-guided Dosing is in the country of Hungary^[8].
• BAX 855 PK-guided Dosing's instance of is recorded as clinical trial^[9].
• BAX 855 PK-guided Dosing's start time is recorded as +2015-11-21T00:00:00Z^[10].
• BAX 855 PK-guided Dosing's end time is recorded as +2018-08-05T00:00:00Z^[11].
• BAX 855 PK-guided Dosing's main subject is recorded as hemophilia A^[12].
• BAX 855 PK-guided Dosing's number of participants is recorded as {'unit': '1', 'amount': '+116'}^[13].
• BAX 855 PK-guided Dosing's title is recorded as Phase 3, Prospective, Randomized, Multi-center Clinical Study Comparing the Safety and Efficacy of BAX 855 Following PK-guided Prophylaxis Targeting Two Different FVIII Trough Levels in Subjects With Severe Hemophilia A^[14].
• BAX 855 PK-guided Dosing's short name is recorded as PROPEL^[15].
• BAX 855 PK-guided Dosing's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}^[16].
• BAX 855 PK-guided Dosing's ClinicalTrials.gov ID is recorded as NCT02585960^[17].
• BAX 855 PK-guided Dosing's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[18].
• BAX 855 PK-guided Dosing's clinical trial phase is recorded as phase III clinical trial^[19].
• BAX 855 PK-guided Dosing's research site is recorded as University of Washington^[20].
• BAX 855 PK-guided Dosing's research site is recorded as University of Colorado Denver^[21].
• BAX 855 PK-guided Dosing's research site is recorded as Tulane University^[22].
• BAX 855 PK-guided Dosing's research site is recorded as University of Nebraska Medical Center^[23].
• BAX 855 PK-guided Dosing's research site is recorded as University of Utah Health Care^[24].
• BAX 855 PK-guided Dosing's research site is recorded as Tel Aviv University^[25].
• BAX 855 PK-guided Dosing's research site is recorded as Kuala Lumpur Hospital^[26].